SSY Group Limited
2005 · HKEX · Hong Kong
Price data from its LJUIF listing on OTC, quoted in USD
ssygroup.com.hkFinancials as of FY2025
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.14B, above the global median of $1.14B
- FinancialsAltman Z-Score 1.75: grey zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
4.50%Above 5Y avg (3.64%)
Annual Rate
HKD 0.11Paid semi-annual
Payout Ratio
45.7%Sustainable
Payback Period
4.7 yr
Last Ex-Dividend
Sep 10, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
8.92BHKD1.14B · vs all stocks (USD)
Trailing P/E
13.56xRevenue (TTM)
4.38BHKD558.74M · vs all stocks (USD)
Profit Margin
11.59%Beta
0.5430xvs all stocks
52-Week Change
-16.72%vs all stocks
Forward Annual Dividend Yield
4.50%vs all stocks
Market Capitalization
8.92BHKD1.14B · vs all stocks (USD)
Enterprise Value
9.84BHKD1.26B · vs all stocks (USD)
Trailing P/E
13.56xForward P/E
9.76xPrice to Sales (TTM)
1.60xPrice to Book (MRQ)
0.9044xEnterprise to Revenue
2.25xEnterprise to EBITDA
8.88xProfit Margin
11.59%Operating Margin
15.30%Return on Assets (TTM)
3.19%Return on Equity (TTM)
6.61%Revenue (TTM)
4.38BHKD558.74M · vs all stocks (USD)
Revenue per Share (TTM)
1.51HKDUpdated Nov 20, 2026Quarterly Revenue Growth
9.90%Gross Profit (TTM)
1.81BHKD231.35M · vs all stocks (USD)
EBITDA (TTM)
1.09BHKD138.88M · vs all stocks (USD)
Net Income (TTM)
507.45MHKD64.75M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
13.00%Operating Cash Flow (TTM)
983.92MHKD125.55M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
879.26MHKD112.19M · vs all stocks (USD)
Forward Annual Dividend Rate
0.1100HKDUpdated Nov 20, 2026Forward Annual Dividend Yield
4.50%vs all stocks
Trailing Annual Dividend Rate
0.0850HKDUpdated Nov 20, 2026Trailing Annual Dividend Yield
3.48%vs all stocks
5-Year Average Dividend Yield
3.64%vs all stocks
Payout Ratio
45.71%Minority Interest (Equity)
319.74MHKDFY2025 · Dec 31, 2025Revenue
4.17BHKDFY2025 · Dec 31, 2025Cost of Goods Sold
2.43BHKDFY2025 · Dec 31, 2025Gross Profit
1.73BHKDFY2025 · Dec 31, 2025Operating Income
583.88MHKD74.50M · vs all stocks (USD)
Pre-tax Income
563.70MHKDFY2025 · Dec 31, 2025Income Tax Expense
80.23MHKDFY2025 · Dec 31, 2025Net Income
483.46MHKDFY2025 · Dec 31, 2025EBIT
669.33MHKDFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.09BHKDFY2025 · Dec 31, 2025Research & Development
244.03MHKDFY2025 · Dec 31, 2025Selling, General & Administrative
774.57MHKDFY2025 · Dec 31, 2025Other Operating Expenses
-21.99MHKDFY2025 · Dec 31, 2025Non-operating Interest Income
21.12MHKDFY2025 · Dec 31, 2025Non-operating Interest Expense
105.63MHKDFY2025 · Dec 31, 2025Minority Interests (P&L)
-12.82MHKDFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00HKDFY2025 · Dec 31, 2025Operating Cash Flow
654.59MHKDFY2025 · Dec 31, 2025Free Cash Flow
487.81MHKDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.69BHKDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
563.70MHKDFY2025 · Dec 31, 2025Other Non-cash Items
52.12MHKDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
27.90MHKDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
10.87MHKDFY2025 · Dec 31, 2025Capital Expenditures
-166.78MHKDFY2025 · Dec 31, 2025Net Intangibles (CF)
-163.68MHKDFY2025 · Dec 31, 2025Net Acquisitions
97.87MHKDFY2025 · Dec 31, 2025Purchase of Investments
0.00HKDFY2025 · Dec 31, 2025Sale of Investments
167.88MHKDFY2025 · Dec 31, 2025Other Investing Activity
94.48MHKDFY2025 · Dec 31, 2025Net Investing Cash Flow
193.45MHKDFY2025 · Dec 31, 2025Long-term Debt Issuance
1.48BHKDFY2025 · Dec 31, 2025Long-term Debt Payments
-1.17BHKDFY2025 · Dec 31, 2025Common Stock Repurchase
-154.45MHKDFY2025 · Dec 31, 2025Common Dividends Paid
-427.08MHKDFY2025 · Dec 31, 2025Net Financing Cash Flow
-274.84MHKDFY2025 · Dec 31, 2025Shares Outstanding
2.90BSharesUpdated Nov 20, 2026Float Shares
964.12MSharesUpdated Nov 20, 2026% Held by Insiders
66.81%vs all stocks
% Held by Institutions
9.74%vs all stocks
Total Cash (MRQ)
1.89BHKD241.24M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.6540HKDUpdated Nov 20, 2026Total Debt (MRQ)
4.05BHKD516.65M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.4977xCurrent Ratio (MRQ)
1.87xBook Value per Share (MRQ)
2.70HKDUpdated Nov 20, 2026Total Assets
12.81BHKD1.63B · vs all stocks (USD)
Total Current Assets
4.96BHKDFY2025 · Dec 31, 2025Total Liabilities
5.19BHKDFY2025 · Dec 31, 2025Total Non-current Assets
7.86BHKDFY2025 · Dec 31, 2025Total Non-current Liabilities
2.57BHKDFY2025 · Dec 31, 2025Total Current Liabilities
2.62BHKDFY2025 · Dec 31, 2025Cash
1.69BHKDFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.69BHKDFY2025 · Dec 31, 2025Other Short-term Investments
46.37MHKDFY2025 · Dec 31, 2025Accounts Receivable
1.66BHKDFY2025 · Dec 31, 2025Inventory
1.20BHKDFY2025 · Dec 31, 2025Accounts Payable
281.75MHKDFY2025 · Dec 31, 2025Short-term Debt
1.77BHKDFY2025 · Dec 31, 2025Long-term Debt
2.25BHKDFY2025 · Dec 31, 2025Common Stock (Book)
65.83MHKDFY2025 · Dec 31, 2025Total Shareholders' Equity
7.62BHKD972.40M · vs all stocks (USD)
52-Week Low
2.01HKDUpdated Nov 20, 202652-Week High
3.15HKDUpdated Nov 20, 202652-Week Change
-16.72%vs all stocks
Beta
0.5430xvs all stocks
50-Day MA
2.67HKDUpdated Nov 20, 2026200-Day MA
2.52HKDUpdated Nov 20, 2026Avg 10-Day Volume
3.00MSharesUpdated Nov 20, 2026Avg 30-Day Volume
3.89MSharesUpdated Nov 20, 2026Diluted EPS (TTM)
0.1800HKDUpdated Nov 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.75: grey zoneSignificant
Altman Z-Score: 1.75
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.14B, above the global median of $1.14BNotable
Market cap (USD): 1,137,947,530.012Global Median: 1,137,180,293.291
Levered free cash flow is $112.19M, above the global median of $18.58MNotable
Levered free cash flow (USD): 112,193,972.07Global Median: 18,579,867.004
Companies that share the same coordination system — how they create, deliver, or capture value.
Inkon Life Tech Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shandong Lukang Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tianjin Ringpu Bio-Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Aurisco Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineFlowRule
BeBetter Med Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Procept BioRobotics Corporation
Tier 1ProductionApproval-Gated PipelineRule
Bio-Thera Solutions Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Guangzhou Wondfo Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Suzhou Novoprotein Scientific Co., Ltd.
Tier 1ProductionApproval-Gated PipelineFlow
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule